Walgreens Boots Alliance Inc
Most Recent
Walgreens Reports Lower Q3 Earnings, Suspends Buybacks
Walgreens Boots Alliance (NASDAQ:WBA) missed Wall Street’s earnings forecast for the third quarter of fiscal 2020, which ended on May 31.
Costco Stock Rose after Reporting Strong Sales in June
On Wednesday, Costco (NASDAQ:COST) reported its net sales for June. For the five weeks ended on July 5, the company reported net sales of $16.18 billion.
Will Walgreens’ Q3 Results Beat Wall Street’s Forecast?
Unlike several other US companies, Walgreens didn’t suspend its dividends due to COVID-19. As of July 6, the company’s dividend yield was 4.2%.
Walmart to Boost Pharmacy Business with CareZone’s Tech Acquisition
Today, CNBC reported that Walmart (NYSE:WMT) has acquired prescription management technology from CareZone to boost its pharmacy space.
Why Walgreens Stock Fell despite Upbeat Q2 Earnings
Walgreens Boots Alliance (NASDAQ:WBA) reported strong earnings for the second quarter of fiscal 2020. The second quarter ended on February 29.
What to Expect from Walgreens’ Q2 Earnings
Analysts expect Walgreen’s second-quarter sales to rise 2.1% YoY to $35.3 billion. The company is scheduled to release its earnings results on April 2.
Bears Return to Walgreens Stock, Challenges Persist
Walgreens Boots Alliance stock is feeling pressure again. The stock fell about 6% on Wednesday, which reflects its weaker start to fiscal 2020.
Can Kroger Gain Momentum in 2020?
Kroger’s performance in recent quarters compared to its peers has left its investors unimpressed. In 2019, Kroger stock rose 5.4%.
Walgreens Posts Disappointing Q1 Earnings Results
Today, Walgreens Boots Alliance reported lower-than-expected results for the first quarter of fiscal 2020. The adjusted EPS fell on a YoY basis.
Alphabet’s Other Bets: Three Things to Know as 2020 Starts
To diversify its business outside the advertising market, Alphabet is building several startup businesses in its Other Bets segment.
Why Walgreens’ Earnings Will Likely Decline in Q1
Walgreens Boots Alliance (WBA) will announce its earnings for the first quarter of fiscal 2020 before the markets open on January 8.
Dow Jones Index’s Top Gains and Losses in 2019
Apple (AAPL) kept the throne with a gain of almost 85% this year. The company is the third biggest component of the Dow Jones Index.
10 Consumer Stocks for Consistent Dividend Income
In addition to boosting dividends, many consumer stocks saw stellar growth in 2019. Most of these companies outperformed the benchmark index YTD.
Consumer Stocks: 5 Stragglers of 2019
Consumer stocks like Macy’s (M), Kraft Heinz (KHC), Gap (GPS), Altria (MO), and Walgreens (WBA) are lagging the broader markets by a wide margin.
Kroger Stocks Gains on Evercore Rating Upgrade
Today, Evercore ISI upgraded its rating on Kroger to “outperform” from “in line” and Citigroup increased its price target on the stock to $32 from $30.
Can FedEx Have a Good Holiday Season sans Amazon?
Delivery companies are poised to benefit from higher online retail sales this holiday season, but FedEx’s split from Amazon could make things dicey for it.
Can the US Cannabis Market Rescue ACB?
Aurora Cannabis (ACB) stock isn’t in the best shape today. As reported by BNN Bloomberg, the company’s CEO, Terry Booth, is justifiably worried.
CVS Health Stock: What’s Fueling Growth and Will the Uptrend Last?
CVS Health stock is up about 13% in November. Strong financial performance is driving the stock higher, but low earnings growth could limit further upside.
FedEx Stock Gains Due to Strong Cyber Monday Projections
FedEx (FDX) stock gained nearly 3% on November 22. The company expects record package volumes on Cyber Monday.
Walgreens: Reports of KKR Buyout Offer, Stock Rose
Walgreens Boots Alliance (WBA) stock rose 5.1% on Monday. Bloomberg reported that private equity firm KKR has formally offered to buy the company.
Kroger versus Walmart: Which Grocery Stock Is Best?
Despite some impressive signs of Kroger’s (K) success, Walmart stock (WMT) is the better pick for the grocery sector. Here’s why.
CVS Keeps Beating Estimates, Raises Earnings Outlook
CVS Health (CVS) again beat analysts’ revenue and EPS estimates when it released its Q3 earnings today. Its stock was up about 3% in premarket trading.
Why Walgreens Is Mulling Over Going Private
Reuters reports that Walgreens Boots Alliance (WBA) is exploring options to go private and has engaged Evercore Partners to put together a deal.
Why CVS Stock Looks Strong Ahead of Q3 Earnings
CVS Health (CVS) is slated to announce its third-quarter earnings results tomorrow. We believe the company sustained its sales momentum in the quarter.
Get Real: Will Unrest in Hong Kong Shape the Market?
Warren Buffett entered the cannabis sector and Boeing experienced another massive loss. Plus, unrest in Hong Kong could hit the market.
Walgreens Stock: Q4 Beat Might Not Spur Recovery
Walgreens Boots Alliance (WBA) struggled in fiscal 2019. Sales headwinds and pressure on margins from reimbursements dragged the stock down.
Walgreens Stock: What to Expect from Its Q4 Earnings
Walgreens is scheduled to report its fourth-quarter earnings before the markets open on October 28. We expected a limited downside in Walgreens stock.
An Overview of the S&P 500 Retailers
US retail sales grew by 3.5% in the first half of 2019. The retail sector of the S&P 500 Index includes 29 stocks representing a broad variety of retailers.
Apple Stock Gains 50%, Drives Dow Jones Higher in 2019
Apple (AAPL) shares have gained close to 50% year-to-date. The stock is trading at $235.87, while it’s valued at $1.07 trillion.
How US Retail Sales Changed in Two Decades
The retail sales for 2018 were $4.3 trillion. From January to July 2019, the retail sales in this category rose 3.5% over the comparable period in 2018.
DJIA Ends Day in Green despite Europe’s Grim Data
The Dow Jones Industrial Average Index or DJIA gained a marginal 0.06% today to close trading just below 27,000—despite a bleak picture in Europe’s economy.
Walgreens Stock Fizzles after Brief Recovery
Pressure on Walgreens (WBA) stock had started easing a bit. However, the revival was short lived, and WBA fell about 2% last week.
FedEx Teams Up with Google Wing to Test Drone Delivery
FedEx (FDX) has teamed up with Alphabet’s (GOOGL) Wing to make drone delivery a reality. Let’s take a closer look at how.
Dow Jones Index Falls after Rising for Eight Days
The Dow Jones Industrial Average Index has fallen 0.4% or by 115 points today. The index is trading lower after rising for eight consecutive trading sessions.
WBA and KHC Stocks Cost Investors despite Recovery
KHC and WBA stocks have cost investors dearly. Warren Buffett’s Berkshire Hathaway has suffered for being Kraft Heinz’s biggest shareholder.
The Dow Jones Rises for Eight Consecutive Days
The Dow Jones Industrial Average has risen 51.5 points today—up for the eighth consecutive trading session. The DJIA is up 1,100 points since September 3.
Walgreens Stock: Deutsche Bank Recommends a ‘Sell’
Deutsche Bank started coverage on Walgreens stock with a “sell” recommendation. The stock closed 4.3% lower on Thursday after the news.
Why Walgreens Stock Underperformed CVS in August
Walgreens Boots Alliance (WBA) stock underperformed CVS Health (CVS) stock last month, with Walgreens falling 6% and CVS rising about 9%.
Walgreens: Pain Eases, but It’s a Far Cry from Recovery
Walgreens stock is underperforming and is trading at a low valuation. Despite this low valuation, the stock’s recovery could take time.
Kroger and Walgreens Expand Their Strategic Partnership
Today, Kroger (KR) and Walgreens Boots Alliance (WBA) announced the expansion of their strategic partnership. Let’s look at the details.
Walgreens or CVS Stock: Which Is a Better Value Buy?
Walgreens and CVS Health shares are trading at a low valuation multiple. The stocks have fallen 22.3% and 8.7%, respectively, in 2019.
Why These Dividend-Paying Consumer Stocks Look Attractive
As the broader markets take a hit, dividend-paying consumer stocks seem like a safe bet due to the sector’s defensive nature.
Walgreens Will Close 200 US Stores
In a regulatory filing on Tuesday, Walgreens Boots Alliance (WBA) announced that it will close 200 stores in the US to focus on store optimization.
Could CVS Health’s Q2 Results Boost Its Stock?
CVS Health (CVS) is set to announce its second-quarter results on August 7. We expect CVS to sustain its momentum in the quarter, supporting its stock.
Walgreens Hikes Dividend, Stock Continues to Underperform
On Wednesday, Walgreens announced a 4% hike in its quarterly dividend. The new quarterly dividend will be payable on September 12.
Amazon Suffers a Blow in Talent Row with CVS Health
Amazon’s (AMZN) efforts to crack the more than $600 billion prescription drug market in the US has suffered a blow, albeit a mild one. A federal judge in Rhode Island ruled on June 18 that a former executive at pharmacy chain CVS Health (CVS) couldn’t work for Amazon’s pharmacy business, PillPack.
What Wall Street Recommends for Walgreens Stock
Wall Street expects Walgreens Boots Alliance’s (WBA) earnings to continue to decline in coming quarters, reflecting higher reimbursement pressure.
Walgreens Boots Alliance Stock: Is Recovery a Long Shot?
Walgreens Boots Alliance (WBA) stock is down about 17% since the company announced weak second-quarter earnings on April 2.
Will Pressure on Earnings Limit the Upside in CVS Health Stock?
CVS Health (CVS) impressed investors with its first-quarter sales and earnings.
CVS Health Stock Rises 5.4% on Strong First-Quarter Earnings
CVS Health (CVS) stock jumped 5.4% on May 1 on stronger-than-expected first-quarter results.
How Analysts Rate CVS Stock
CVS Health (CVS) stock is trading at 7.8x its 2019 estimated EPS of $6.79.
What to Expect from CVS Health’s First-Quarter Results
CVS Health (CVS) plans to announce its first-quarter results on Wednesday, May 1.
What Analyst Ratings Indicate for CVS Stock
Among the 27 analysts covering CVS Health (CVS) stock, 18 analysts suggest a “buy,” and nine analysts recommend a “hold.”
Oppenheimer Downgrades CVS Health Stock to ‘Perform’
On April 15, Oppenheimer downgraded CVS Health (CVS) stock to “perform” from “outperform.”
Pharmaceutical Retailers Underperformed Broader Markets
CVS and Walgreens stock fell 17.7% and 7.4%, respectively, in the first quarter, which reflected the weak earnings outlook.
Consumer Staples Stocks: Stragglers in Q1
Despite 10.5% growth in the first quarter, the Consumer Staples Select Sector SPDR ETF (XLP) lagged the benchmark index, which rose 13.1%.
What’s the Potential Upside in CVS and WBA Stock?
Analysts maintain a positive outlook on CVS Health (CVS) stock.
Are CVS and Walgreens Stock Too Cheap to Ignore?
CVS Health (CVS) is down 19.4% on a YTD basis as of April 3.
What Analysts Recommend for Walgreens after Q2
Most analysts maintain a “hold” rating on Walgreens Boot Alliance (WBA) stock.
What Affected Walgreens’s Q2 EPS?
Walgreens Boots Alliance (WBA) posted adjusted earnings of $1.64 per share, a 5.4% decrease on a YoY basis.
Why Walgreens Missed Analysts’ Sales Estimate in Q2
Walgreens Boots Alliance’s (WBA) second-quarter sales of $34.5 billion increased 4.6% on a YoY basis.
Walgreens Stock Fell ~13% on Weak Q2 and Lower Guidance
Walgreens Boots Alliance (WBA) stock dropped 12.8% on Tuesday, April 2.
Walgreens’ Weak Q2 Results Weigh on Its Stock
Walgreens Boots Alliance (WBA) reported dismal results for the second quarter of fiscal 2019 on April 2.
Walgreens Stock: Why Analysts Lowered the Target Price
Analysts lowered their target price on Walgreens Boot Alliance (WBA) stock. On March 27, Cowen lowered its target price to $66 from $75.
Amazon Challenges Walgreens and CVS Health Again
Amazon (AMZN) recently began letting customers use funds in their special healthcare savings account to pay for purchases of eligible products on its marketplace, the company confirmed to CNBC.
Walgreens Stock Continues to Fall Due to Multiple Price Cuts
Walgreens Boot Alliance (WBA) shares have taken a beating the past few days. Multiple analysts lowered their target price on the stock.
Walgreens’s Digital Transformation Is Good News for Alibaba
Part of Walgreen’s (WBA) ongoing digital transformation involves making shopping more convenient for its customers.
Walgreens and CVS Stocks Look Attractive despite Challenges
Walgreens Boots Alliance (WBA) and CVS Health (CVS) shares have taken a beating. Bottom-line challenges spooked investors.
What’s Hurting CVS and Walgreens Stocks?
Walgreens Boots Alliance stock (WBA) fell 6.4% on March 1 after Baird’s reduction in target price.
How Microsoft Has Fared with Nadella as CEO
Satya Nadella took over as CEO at Microsoft five years ago. Microsoft stock has risen almost 182% since Nadella took the reins.
Here’s What the Microsoft-Walgreens Deal Indicates
Microsoft (MSFT) and Walgreens (WBA) announced last month that they would cooperate on developing digital healthcare solutions.
Will Walgreens’s Cost Management Improve Its Margins?
Walgreens Boots Alliance’s (WBA) gross margin continued to contract in the first quarter of fiscal 2019 after contracting in fiscal 2018.
Will Walgreens’s Strategic Initiatives Boost Its Sales?
Walgreens Boots Alliance’s (WBA) sales rose 9.9% to $33.8 billion in the first quarter of fiscal 2019 (which ended on November 30, 2018).
How Is Walgreens Boots Alliance Positioned in 2019?
As of January 18, Walgreens Boots Alliance (WBA) stock has risen 6.0% since the start of 2019.
Microsoft and Walgreens Sign Major Deal
Earlier this morning, American tech giant Microsoft (MSFT) announced its strategic partnership with pharmaceutical firm Walgreens Boots Alliance (WBA).
Why Walgreens Stock Fell despite Beating Estimates
Walgreens Boots Alliance (WBA) posted better-than-expected first-quarter results on Thursday, December 20.
Five Consumer Staples Stocks to Be Thankful For—Even This Year
So far, 2018 has been a difficult year for the consumer staples industry—even tougher than last year.
CVS: Analysts’ Ratings and Target Prices
CVS Health posted stronger-than-expected third-quarter results on November 6. A few analysts raised the target prices on CVS stock.
CVS’s Q3 Sales Beat the Estimate
CVS Health (CVS) reported stronger-than-expected third-quarter sales. The company reported net sales of $47.3 billion.
CVS Stock Rose 5.7% Due to Strong Third-Quarter Results
CVS reported better-than-expected third-quarter results on November 6. The company’s top and bottom line exceeded analysts’ estimates.
How Investors Reacted to Walgreens’s Fourth-Quarter Results
Walgreens stock has fallen 2.4% YTD (year-to-date). It fell ~10% after Amazon announced the acquisition of Pillpack in June.
Walgreens: Key Revenue Drivers in Fourth Quarter of Fiscal 2018
Walgreens’s Retail Pharmacy USA division accounted for 76% of fourth-quarter sales and increased 14.4% YoY to $25.5 billion.
Walgreens Stock Rises as RBC Increases Price Target 20%
RBC Capital Markets raised the price target for Walgreens Boots Alliance (WBA) from $68 to $82 (or ~20%) on Monday, October 8.
Rite Aid Reports in-Line EPS in the Second Quarter
Rite Aid (RAD) reported a second-quarter adjusted net loss from continuing operations of $7.9 million or $0.01 loss per share.
Rite Aid Finally Posts Top-Line Growth in the Second Quarter
Rite Aid (RAD) reported results for the second quarter—which ended on September 1—yesterday. The company’s top line from continuing operations improved 1.4 % YoY (year-over-year) to $5.42 billion.
After Two Failed Mergers, Where Does Rite Aid Stand Now?
Struggling with the company’s financial position, Rite Aid’s management has tried to sell the company’s assets since 2015.
Strong Q2 2018 Results Cushion CVS Health’s Falling Share Price
CVS Health’s (CVS) better-than-expected second-quarter results managed to please investors.
How Pharmacies and Drugstores Are Defending against Amazon
Amazon’s (AMZN) purchase of PillPack is expected to pose a threat to existing players in the pharmaceutical space.
Here’s Why Walgreens Stock Crashed despite Strong Q3 Results
After Walgreens announced its fiscal Q3 results, Amazon announced its plan to acquire PillPack, an online pharmacy company, and WBA stock crashed.
What Drove Walgreens’s Fiscal Third-Quarter Top Line?
Walgreens’s Retail Pharmacy USA division, which accounted for 75% of third-quarter sales, recorded a 15% YoY increase in revenue.
Walgreens Reports 14% Sales Growth in Fiscal Third Quarter
Walgreens’s fiscal third-quarter top line increased 14% YoY to $34.3 billion. On a constant currency basis, sales rose 11.8% YoY.
Why Walgreens Beat Expectations in Its Third Fiscal Quarter
Walgreens Boots Alliance (WBA) reported its results for its third fiscal quarter, which ended on May 31, before the bell this morning.
Rite Aid’s Fiscal Q1 2019 Beat Drives Its Stock After Hours
Rite Aid’s (RAD) better-than-expected results drove its stock by 1.5% in the post-trading session on June 27.
Top Gainers in the Consumer Sector Last Week
Campbell Soup Company rose 4.0% last week after a New York Post report mentioned that Kraft Heinz Company (KHC) would be interested in buying Campbell Soup if the company is up for sale.
Analysts Aren’t So Sure about Rite Aid Stock
After a disastrous 2017, Rite Aid stock has managed to stay in the green so far this year.
Why the Dow Jones Industrial Index Dropped General Electric
On June 19, the S&P Dow Jones Indexes issued a press release stating that Walgreens Boots Alliance (WBA) would replace General Electric (GE) in the Dow Jones Industrial Average (DJIA).
Walgreens Replaces General Electric in Dow Jones
On June 19, the S&P Dow Jones Indexes announced that Walgreens Boots Alliance would replace General Electric in the Dow Jones Industrial Average Index.
CVS Health and Walgreens: Financial Health
CVS recorded total sales of $186 billion (+4% YoY) in the last 12 months. The Pharmacy Services segment was the company’s biggest moneymaker.
CVS Health versus Walgreens: Comparing Pharmacy Giants
Around 70% of the US population lives within three miles of a CVS store, while more than 75% of the population lives within five miles of a Walgreens store.
Drugstore Stocks Tumble ahead of Trump’s New Drug Policy
The stocks of top drugstore chains CVS Health (CVS) and Walgreens Boots Alliance (WBA) were down yesterday amid ongoing tensions regarding a policy change in US drug pricing.